Upregulation and activation of NF-κB contribute to unregulated cell proliferation in cancer cells, given that NF-κB transcription factors regulate the expression of cell cycle regulators such as cyclin A, cyclin D1, or cyclin-dependent kinase 6 (CDK6). The gene discussed is CCNA2; the disease is cancer.